EN DE
STOCK COMPARISON

Galenica Sante vs McKesson: Fair Value & Quality

Both stocks run through our valuation models. Here is how Galenica Sante (GALE) and McKesson (MCK) compare, as of Sep 5, 2026.

As of Sep 5, 2026, Fair Value Calculator sees McKesson as the less overvalued of the two: Galenica Sante trades at CHF 82.90 versus a fair value of CHF 61.79 (-25%), while McKesson trades at $921 versus $819 (-11%).
Galenica Sante
GALE.SW · CHF · Health Care
-25%
upside to fair value
overvalued
PriceCHF 82.90
Fair ValueCHF 61.79
Quality60/100
McKesson
MCK · USD · Health Care
-11%
upside to fair value
overvalued
Price$921
Fair Value$819
Quality67/100
Get comparisons like this free by email every month: the most undervalued quality stocks.

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

Galenica SanteMcKesson
Valuation
23.6×P/E (TTM)21.0×
1.28×P/S (TTM)0.23×
3.59×P/B—
21.7×EV/EBITDA13.9×
—PEG1.57×
−25.5%Fair value upside−11.1%
3.0%Dividend yield0.3%
CHF 2.50Dividend per share$3.17
Profitability
6%Operating margin2%
0.93×EBIT margin trend (5Y)1.60×
12%Return on equity—
4%Return on assets5%
Growth
6%Revenue growth (YoY)6%
1.0%Avg. growth/yr (3Y)13.4%
3.5%Avg. growth/yr (5Y)11.1%
+4.4%Value creation/yr+44.8%
Balance & size
14.2×Interest coverage (EBIT/interest)26.1×
0.41×Debt / equity—
$5BMarket cap$94B
healthyGrowth qualityhealthy

McKesson leads: 2 to 10 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Galenica Santeof which business quality 60 · market factors 50 McKessonof which business quality 65 · market factors 70
ProfitabilityMargins and returns on capital today
48
49
Quality GrowthAre margins and returns improving?
31
65
CashflowEarnings quality: real cash, not paper profit
61
47
Fin. StrengthBalance sheet, leverage, solvency risk
69
72
InvestmentDisciplined investing over empire-building
77
76
Low VolatilityCalm price path (market factor)
98
83
MomentumPrice trend over the last 3–12 months (market factor)
35
60
52W MomentumDistance to the 52-week high (market factor)
20
75
Net IssuanceBuybacks instead of dilution
81
100

What the models say

How far the median fair value (base case) per model family sits from the current price, in percent. The amount in the currency of the trading venue is shown underneath.

above the price, more than 15% above close to the price, 85% to 115% of the price below the price, more than 15% below

Model familyGalenica SantePrice CHF 82.90McKessonPrice $921
DCF Models-18%below the priceCHF 68.32+4%close to the price$955
Earnings-Based-65%below the priceCHF 29.18-52%below the price$444
Dividend Discount-62%below the priceCHF 31.67-94%below the price$57.26
Multiples-23%below the priceCHF 64.03-8%close to the price$848
Asset-Based-76%below the priceCHF 19.93n/a
Growth DCF-25%below the priceCHF 62.110%close to the price$922
Economic Profit-63%below the priceCHF 30.42-46%below the price$497
Growth Earnings-22%below the priceCHF 64.59-23%below the price$708
Minimum-76%below the priceCHF 19.93-94%below the price$57.26
Maximum-18%below the priceCHF 68.32+4%close to the price$955
Median-43%below the priceCHF 46.89-23%below the price$708
Geometric mean-49%below the priceCHF 42.08-47%below the price$489

Minimum, maximum, median and geometric mean refer to the family values in this table. Geometric because deviations are ratios: half the price and twice the price average to 100%, not 125%.

Galenica Sante: 24 of 25 models see the stock below the current price.

McKesson: 15 of 23 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

Galenica Sante
Bear CHF 46.34Fair Value CHF 61.79Bull CHF 77.24
CHF 82.90 = current price (white tick)
McKesson
Bear $605Fair Value $819Bull $1,034
$921 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Galenica Sante · Health Care

Quality score60 · above median
Fair value upside-25% · above median

McKesson · Health Care

Quality score67 · Top 25%
Fair value upside-11% · above median

Bottom line

As of Sep 5, 2026, Fair Value Calculator sees McKesson as the less overvalued of the two: Galenica Sante trades at CHF 82.90 versus a fair value of CHF 61.79 (-25%), while McKesson trades at $921 versus $819 (-11%).

McKesson has the higher quality score (67/100).

See the full analysis →
Galenica Sante · McKesson

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Related to Galenica Sante

Eli Lilly and vs UnitedHealth GroupJohnson & Johnson vs UnitedHealth GroupAbbVie vs UnitedHealth GroupMerck & Company vs UnitedHealth Group

Related to McKesson

AstraZeneca vs UnitedHealth GroupThermo Fisher Scientific vs UnitedHealth GroupAmgen vs UnitedHealth GroupAbbott Laboratories vs UnitedHealth Group
Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 26 models. Values change with price and fundamentals; the date shown above applies.